Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 6 of 35

RECRUITING

The Gastric Cancer Foundation: A Gastric Cancer Registry

NCT01514045

RECRUITING

Filter Initial & Long Term Evaluation After Placement and Retrieval Registry

NCT01158482

RECRUITING

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT01019148

RECRUITING

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

NCT04828603

RECRUITING

Evaluation of Patients With Non-obstructive Coronary Arteries

NCT00823563

RECRUITING

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

NCT00373347

RECRUITING

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

NCT01048281

RECRUITING

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

NCT00230308

RECRUITING

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

NCT00349830

RECRUITING

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT01034033

RECRUITING

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

NCT00398177

RECRUITING

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT00568490

RECRUITING NA

Magnetic Resonance Imaging of Breast Cancer

NCT01035112

RECRUITING

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

NCT01629017

ACTIVE NOT RECRUITING

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

NCT07308860

ACTIVE NOT RECRUITING NA

Comparison of Two Nutrition-Based Interventions on Physician Well-being

NCT06598540

ACTIVE NOT RECRUITING Phase 4

Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression

NCT06317636

ACTIVE NOT RECRUITING NA

IGNITE Firefighters' Health

NCT06567561

ACTIVE NOT RECRUITING

Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

NCT06603441

ACTIVE NOT RECRUITING NA

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

NCT05858879

ACTIVE NOT RECRUITING NA

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

NCT06824441

ACTIVE NOT RECRUITING NA

Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures

NCT06234228

ACTIVE NOT RECRUITING NA

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

NCT06050135

ACTIVE NOT RECRUITING NA

The Effect of a Bioactive Fabric Sleeve

NCT06234202

ACTIVE NOT RECRUITING NA

Testing Multi-Level Remote Physical Activity Interventions in a National Sample of Older Women: The WHISH EnCore Trial

NCT05566873

ACTIVE NOT RECRUITING NA

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

NCT06052137

ACTIVE NOT RECRUITING NA

Virtually Supervised Exercise for Kidney Transplant Candidates

NCT05355545

ACTIVE NOT RECRUITING NA

Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being

NCT06014281

ACTIVE NOT RECRUITING Phase 1

Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia

NCT05993949

ACTIVE NOT RECRUITING NA

Project AFECT (Autism Family Empowerment Coaching and Training Program)

NCT05910502

ACTIVE NOT RECRUITING NA

Healthcare Worker Resilience as Measured by Physiologic Feedback

NCT05033379

ACTIVE NOT RECRUITING

Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

NCT05916378

ACTIVE NOT RECRUITING

The BEAR Therapeutic Program for Women

NCT04418778

ACTIVE NOT RECRUITING NA

HIIT vs. MICT Training Study

NCT05513300

ACTIVE NOT RECRUITING

The Lasting Change Study

NCT05719129

ACTIVE NOT RECRUITING NA

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

NCT05377723

ACTIVE NOT RECRUITING NA

Childcare Healthy Beverage Access, Food and Beverage Intake, and Obesity

NCT05112185

ACTIVE NOT RECRUITING NA

Vida Sana y Completa Obesity and Food Insecurity Study

NCT05211180

ACTIVE NOT RECRUITING Phase 1

Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL

NCT05507827

ACTIVE NOT RECRUITING Phase 2

Study Assessing QBS72S For Treating Brain Metastases

NCT05305365

ACTIVE NOT RECRUITING Phase 2

Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

NCT05203835

ACTIVE NOT RECRUITING Phase 3

Descemet Endothelial Thickness Comparison Trial I

NCT05289661

ACTIVE NOT RECRUITING Phase 2

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

NCT04788043

ACTIVE NOT RECRUITING NA

Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain

NCT05079984

ACTIVE NOT RECRUITING Early Phase 1

Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome

NCT05485207

ACTIVE NOT RECRUITING NA

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging

NCT04981223

ACTIVE NOT RECRUITING NA

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

NCT05037175

ACTIVE NOT RECRUITING

Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation

NCT04994249

ACTIVE NOT RECRUITING NA

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

NCT05829681

ACTIVE NOT RECRUITING NA

Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)

NCT05343793

← Previous Page 6 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.